VYCOR MEDICAL INC (VYCO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 700K 1.4M 2.1M Q4 '11: 971.4K Q1 '12: 1.3M Q2 '12: 1.4M Q3 '12: 1.4M Q4 '12: 1.2M Q1 '13: 1M Q2 '13: 973.9K Q3 '13: 1.1M Q4 '13: 1.1M Q1 '14: 1.2M Q2 '14: 1.3M Q3 '14: 1.3M Q4 '14: 1.3M Q1 '15: 1.2M Q2 '15: 1.2M Q3 '15: 1.1M Q4 '15: 1.1M Q1 '16: 1.2M Q2 '16: 1.3M Q3 '16: 1.4M Q4 '16: 1.5M Q1 '17: 1.5M Q2 '17: 1.4M Q3 '17: 1.5M Q4 '17: 1.4M Q1 '18: 1.3M Q2 '18: 1.3M Q3 '18: 1.4M Q4 '18: 1.5M Q1 '19: 1.5M Q2 '19: 1.6M Q3 '19: 1.5M Q4 '19: 1.4M Q1 '20: 1.4M Q2 '20: 1.2M Q3 '20: 1.2M Q4 '20: 1.1M Q1 '21: 1.1M Q2 '21: 1.4M Q3 '21: 1.4M Q4 '21: 1.4M Q1 '22: 1.4M Q2 '22: 1.2M Q3 '22: 1.2M Q4 '22: 1.2M Q1 '23: 1.3M Q2 '23: 1.4M Q3 '23: 1.4M Q4 '23: 1.5M Q1 '24: 1.4M Q2 '24: 1.4M Q3 '24: 1.4M Q4 '24: 1.6M Q1 '25: 1.7M Q2 '25: 1.8M Q3 '25: 1.9M Q4 '25: 1.9M Q1 '26: 1.9M Q2 '26: 1.8M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Gross Profit TTM

0 600K 1.2M 1.8M Q4 '10: 267.7K Q1 '11: 338.8K Q2 '11: 377.3K Q3 '11: 513K Q4 '11: 795.1K Q1 '12: 1M Q2 '12: 1.1M Q3 '12: 1.1M Q4 '12: 1M Q1 '13: 874.2K Q2 '13: 856.1K Q3 '13: 941.2K Q4 '13: 935.5K Q1 '14: 1M Q2 '14: 1.1M Q3 '14: 1.1M Q4 '14: 1.1M Q1 '15: 1.1M Q2 '15: 1M Q3 '15: 974.5K Q4 '15: 974.5K Q1 '16: 1M Q2 '16: 1.1M Q3 '16: 1.2M Q4 '16: 1.3M Q1 '17: 1.3M Q2 '17: 1.3M Q3 '17: 1.3M Q4 '17: 1.2M Q1 '18: 1.1M Q2 '18: 1.1M Q3 '18: 1.1M Q4 '18: 1.3M Q1 '19: 1.4M Q2 '19: 1.5M Q3 '19: 1.4M Q4 '19: 1.3M Q1 '20: 1.3M Q2 '20: 1.1M Q3 '20: 1M Q4 '20: 1M Q1 '21: 983.9K Q2 '21: 1.2M Q3 '21: 1.3M Q4 '21: 1.3M Q1 '22: 1.3M Q2 '22: 1.1M Q3 '22: 1.1M Q4 '22: 1.1M Q1 '23: 1.1M Q2 '23: 1.3M Q3 '23: 1.3M Q4 '23: 1.3M Q1 '24: 1.3M Q2 '24: 1.2M Q3 '24: 1.3M Q4 '24: 1.4M Q1 '25: 1.5M Q2 '25: 1.5M Q3 '25: 1.6M Q4 '25: 1.6M Q1 '26: 1.6M Q2 '26: 1.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating Income TTM

-6M -4M -2M 0 2M 4M 6M Q4 '10: -1.9M Q1 '11: -2.5M Q2 '11: -3.9M Q3 '11: -4.7M Q4 '11: -4.6M Q1 '12: -4.5M Q2 '12: -3.4M Q3 '12: -3.1M Q4 '12: -2.8M Q1 '13: -2.6M Q2 '13: -2.5M Q3 '13: -2.2M Q4 '13: -2.3M Q1 '14: -2.7M Q2 '14: -2.8M Q3 '14: -2.7M Q4 '14: -2.7M Q1 '15: -2.3M Q2 '15: -2.1M Q3 '15: -2.2M Q4 '15: -2M Q1 '16: -1.9M Q2 '16: -1.7M Q3 '16: -1.5M Q4 '16: -1.6M Q1 '17: -1.4M Q2 '17: -1.4M Q3 '17: -1.4M Q4 '17: -1.3M Q1 '18: -1.3M Q2 '18: -1.4M Q3 '18: -1.2M Q4 '18: -1.3M Q1 '19: -1.2M Q2 '19: -890.9K Q3 '19: -923.9K Q4 '19: -634.7K Q1 '20: -618.5K Q2 '20: -687.3K Q3 '20: -728K Q4 '20: -727.4K Q1 '21: -787.5K Q2 '21: -564.7K Q3 '21: -446.7K Q4 '21: -436K Q1 '22: -282K Q2 '22: -379.9K Q3 '22: -379.5K Q4 '22: -306.5K Q1 '23: -220.4K Q2 '23: -49.5K Q3 '23: 13.1K Q4 '23: 40.2K Q1 '24: -2.5K Q2 '24: -82.9K Q3 '24: -92.5K Q4 '24: -9.1K Q1 '25: -12.4K Q2 '25: 22.5K Q3 '25: 89.8K Q4 '25: 33.9K Q1 '26: 92.5K Q2 '26: 48.2K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-6M -4M -2M 0 2M 4M 6M Q4 '11: -4.8M Q1 '12: -4.6M Q2 '12: -3.6M Q3 '12: -3.2M Q4 '12: -2.9M Q1 '13: -2.8M Q2 '13: -2.7M Q3 '13: -2.4M Q4 '13: -2.5M Q1 '14: -2.6M Q2 '14: -3.2M Q3 '14: -4M Q4 '14: -4M Q1 '15: -4M Q2 '15: -3.1M Q3 '15: -2.3M Q4 '15: -2.1M Q1 '16: -1.9M Q2 '16: -1.8M Q3 '16: -1.6M Q4 '16: -1.7M Q1 '17: -1.4M Q2 '17: -1.5M Q3 '17: -1.6M Q4 '17: -1.5M Q1 '18: -1.5M Q2 '18: -1.5M Q3 '18: -1.3M Q4 '18: -1.4M Q1 '19: -1.2M Q2 '19: -999.7K Q3 '19: -1.1M Q4 '19: -796.2K Q1 '20: -790.9K Q2 '20: -854.4K Q3 '20: -843.1K Q4 '20: -822.5K Q1 '21: -890.5K Q2 '21: -650.9K Q3 '21: -449K Q4 '21: -435.7K Q1 '22: -267.3K Q2 '22: -356.9K Q3 '22: -475.4K Q4 '22: -404.9K Q1 '23: -323.5K Q2 '23: -156.1K Q3 '23: -93.2K Q4 '23: -69.7K Q1 '24: -107.2K Q2 '24: -185.6K Q3 '24: -193.5K Q4 '24: -107.2K Q1 '25: -115.2K Q2 '25: -81.2K Q3 '25: -16.5K Q4 '25: -72.4K Q1 '26: -13.8K Q2 '26: -59.9K Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 150K 300K 450K Q4 '17: 227.1K Q1 '18: 208.5K Q2 '18: 216K Q3 '18: 207.5K Q4 '18: 169.6K Q1 '19: 176.5K Q2 '19: 165.6K Q3 '19: 147.7K Q4 '19: 138.6K Q1 '20: 139.7K Q2 '20: 124.1K Q3 '20: 135.7K Q4 '20: 132.5K Q1 '21: 123.6K Q2 '21: 142.5K Q3 '21: 137.1K Q4 '21: 134.7K Q1 '22: 139.7K Q2 '22: 128.2K Q3 '22: 135.3K Q4 '22: 140.6K Q1 '23: 138K Q2 '23: 149.9K Q3 '23: 140.1K Q4 '23: 144.9K Q1 '24: 151.2K Q2 '24: 146.5K Q3 '24: 151K Q4 '24: 166.8K Q1 '25: 207.6K Q2 '25: 253.6K Q3 '25: 278.6K Q4 '25: 302.3K Q1 '26: 307.8K Q2 '26: 300.6K Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '11: -2.8M Q4 '11: -3.2M Q1 '12: -3M Q2 '12: -2.5M Q3 '12: -1.8M Q4 '12: -1.4M Q1 '13: -1.2M Q2 '13: -1.2M Q3 '13: -969.1K Q4 '13: -730.1K Q1 '14: -1.6M Q2 '14: -2M Q3 '14: -2.2M Q4 '14: -2.7M Q1 '15: -2M Q2 '15: -1.7M Q3 '15: -1.7M Q4 '15: -1.2M Q1 '16: -865.7K Q2 '16: -798.5K Q3 '16: -479.1K Q4 '16: -496.9K Q1 '17: -539.6K Q2 '17: -363.6K Q3 '17: -462.5K Q4 '17: -527.4K Q1 '18: -429.3K Q2 '18: -528K Q3 '18: -462.4K Q4 '18: -260.3K Q1 '19: -133.7K Q2 '19: -40.6K Q3 '19: 15K Q4 '19: -6K Q1 '20: -22.6K Q2 '20: -54.8K Q3 '20: -238.1K Q4 '20: -248.8K Q1 '21: -248.3K Q2 '21: -117.4K Q3 '21: -16K Q4 '21: 21.4K Q1 '22: -23.3K Q2 '22: -137.9K Q3 '22: -152.2K Q4 '22: -217K Q1 '23: -113.6K Q2 '23: -71.3K Q3 '23: -9.4K Q4 '23: 29.4K Q1 '24: 6.7K Q2 '24: 78.6K Q3 '24: 103.9K Q4 '25: -13.5K Q1 '26: 112.9K Q2 '26: 61.4K Q1 '13 Q4 '14 Q3 '16 Q2 '18 Q1 '20 Q4 '21 Q3 '23 Q2 '26

Free Cash Flow TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '11: -2.8M Q4 '11: -3.2M Q1 '12: -3.1M Q2 '12: -2.6M Q3 '12: -1.9M Q4 '12: -1.4M Q1 '13: -1.3M Q2 '13: -1.2M Q3 '13: -1.1M Q4 '13: -858.2K Q1 '14: -1.8M Q2 '14: -2.1M Q3 '14: -2.3M Q4 '14: -2.8M Q1 '15: -2.2M Q2 '15: -1.8M Q3 '15: -1.7M Q4 '15: -1.4M Q1 '16: -1.1M Q2 '16: -1M Q3 '16: -670.3K Q4 '16: -554.4K Q1 '17: -651.2K Q2 '17: -488.8K Q3 '17: -652K Q4 '17: -710.7K Q1 '18: -554.5K Q2 '18: -673.3K Q3 '18: -541.9K Q4 '18: -323.8K Q1 '19: -190.3K Q2 '19: -59.7K Q3 '19: -13.5K Q4 '19: -58.9K Q1 '20: -115.8K Q2 '20: -152K Q3 '20: -329.6K Q4 '20: -310.8K Q1 '21: -287.7K Q2 '21: -161.7K Q3 '21: -56.6K Q4 '21: -17K Q4 '12 Q2 '14 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '21: 27.8M Q2 '21: 29.7M Q3 '21: 30.2M Q1 '22: 30.8M Q2 '22: 31.5M Q3 '22: 32M Q1 '23: 32.5M Q2 '23: 37.5M Q3 '23: 32.6M Q1 '24: 32.6M Q2 '24: 32.6M Q3 '24: 32.9M Q1 '25: 33.4M Q2 '25: 38.7M Q3 '25: 33.4M Q1 '26: 33.4M Q2 '26: 33.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q4 '10: -0.00 Q1 '11: -0.00 Q2 '11: -0.01 Q3 '11: -0.00 Q4 '11: -0.92 Q1 '12: -1.06 Q2 '12: -1.20 Q3 '12: -1.34 Q4 '12: -0.52 Q1 '13: -0.49 Q2 '13: -0.45 Q3 '13: -0.39 Q4 '13: -0.39 Q1 '14: -0.37 Q2 '14: -0.39 Q3 '14: -0.43 Q4 '14: -0.39 Q1 '15: -0.37 Q2 '15: -0.29 Q3 '15: -0.22 Q4 '15: -0.19 Q1 '16: -0.18 Q2 '16: -0.17 Q3 '16: -0.16 Q4 '16: -0.18 Q1 '17: -0.15 Q2 '17: -0.14 Q3 '17: -0.13 Q4 '17: -0.10 Q1 '18: -0.09 Q2 '18: -0.09 Q3 '18: -0.07 Q4 '18: -0.07 Q1 '19: -0.06 Q2 '19: -0.05 Q3 '19: -0.06 Q4 '19: -0.05 Q1 '20: -0.05 Q2 '20: -0.05 Q3 '20: -0.04 Q4 '20: -0.03 Q1 '21: -0.03 Q2 '21: -0.02 Q1 '23: -0.01 Q2 '23: -0.01 Q1 '26: 0.00 Q2 '26: 0.00 Q4 '11 Q2 '13 Q4 '14 Q2 '16 Q4 '17 Q2 '19 Q4 '20 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.